Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: Measles Now Has a Drug - NV-387 Broad-Spectrum Antiviral Successful ...

(PR-inside.com) SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced that it has achieved significant success in developing a drug against Measles.

Strong antiviral effectiveness against Measles virus was found for NV-387, the Company's broad-spectrum drug candidate, in a humanized animal model study.

"NV-387 is on its way to become the very first drug to treat Measles," said Anil R. Diwan, PhD, adding, "Measles cases are skyrocketing ..

https://reports.pr-inside.com/measles-n ... 121189.htm
Copyright PR-Inside.com 2025